Vaxart, Inc. (VXRT)
$0.46+6.98%Close
SELLRECOVERY · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $111M
- Beta
- 1.06
- P/E (TTM)
- 3.04
- Short % float
- 0.98%
- Days to cover
- 4.7
- SI change
- +0.9%
- 1W
- +4.55%
- 1M
- -6.12%
- vs SPY 1W
- +4.68%
- vs SPY 1M
- -8.63%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on VXRT?
- LOPJLB’s latest quantitative signal on Vaxart, Inc. (VXRT) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is VXRT in?
- Vaxart, Inc. (VXRT) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Vaxart, Inc. (VXRT) do?
- Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates: An oral tablet vaccine targeting norovirus, which …